11 days ago
AXSM
AnalystsYatin SunejaYatin Suneja's Stock Forecasts
AnalystsYatin Suneja
Analyst Ranking
Top 3%
#112 out of 5278 analysts
Average Return
+29.13%
Win Rate
62%106 out of 172
Risk vs Reward
Poor
Good
Yatin Suneja's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alumis IncALMS | +580.65% | $3.36 | $22.87 | 2025-06-10 - 2026-05-15 | Strong Buy |
Reata Pharmaceuticals IncRETA | +376.00% | $36.21 | $172.36 | 2022-10-19 - 2023-09-25 | Strong Buy |
Phathom Pharmaceuticals IncPHAT | +335.14% | $2.76 | $12.01 | 2025-05-02 - 2026-05-01 | Strong Buy |
Zura Bio LtdZURA | +320.97% | $1.34 | $5.62 | 2025-03-26 - 2026-03-25 | Strong Buy |
Dianthus Therapeutics IncDNTH | +291.96% | $21.90 | $85.84 | 2025-03-12 - 2026-03-11 | Strong Buy |
Yatin Suneja Analyst Color
Get additional color on Yatin Suneja's coverage of popular stocks
a month ago
ORKA
2 months ago
AXSM
2 months ago
CABA
2 months ago
ZBIO
2 months ago
DNTH
3 months ago
PHAT
3 months ago
PRAX
4 months ago
ALMS
5 months ago
DBVT
5 months ago
PRAX
6 months ago
IFRX
7 months ago
PRAX
7 months ago
ABVX
7 months ago
ACET
8 months ago
ROIV
9 months ago
NBIX
9 months ago
ARGX
10 months ago
ABVX
2 years ago
ARGX
2 years ago
SYRE
2 years ago
CLDX
2 years ago
AXSM
2 years ago
LBPH
3 years ago
ARGX
Yatin Suneja's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Alumis IncALMS | 4 | Strong Buy | $34.00 | +48.67% | Maintains | a day ago |
Argenx SeARGX | 13 | Strong Buy | $1,135.00 | +42.00% | Maintains | 8 days ago |
Neurocrine Biosciences IncNBIX | 7 | Strong Buy | $175.00 | +10.47% | Reiterates | 10 days ago |
Axsome Therapeutics IncAXSM | 11 | Strong Buy | $260.00 | +14.18% | Maintains | 11 days ago |
Dbv Technologies SaDBVT | 4 | Strong Buy | $51.00 | +159.54% | Reiterates | 12 days ago |
Regeneron Pharmaceuticals IncREGN | 10 | Strong Buy | $995.00 | +42.50% | Maintains | 15 days ago |
Biogen IncBIIB | 5 | Strong Buy | $260.00 | +34.75% | Maintains | 16 days ago |
Inflarx NvIFRX | 6 | Strong Buy | $14.00 | +466.80% | Reiterates | 25 days ago |
Oruka Therapeutics IncORKA | 5 | Strong Buy | $125.00 | +101.84% | Reiterates | a month ago |
Neumora Therapeutics IncNMRA | 3 | Strong Buy | $14.00 | +660.87% | Reiterates | 2 months ago |
Cabaletta Bio IncCABA | 7 | Strong Buy | $16.00 | +383.38% | Maintains | 2 months ago |
Immunic IncIMUX | 1 | Strong Buy | $70.00 | +479.47% | Initiates Coverage On | 2 months ago |
Zenas Biopharma IncZBIO | 3 | Strong Buy | $55.00 | +164.93% | Maintains | 2 months ago |
Adicet Bio IncACET | 4 | Strong Buy | $100.00 | +1,202.08% | Maintains | 2 months ago |
Dianthus Therapeutics IncDNTH | 3 | Strong Buy | $200.00 | +132.13% | Maintains | 2 months ago |
Sionna Therapeutics IncSION | 1 | Strong Buy | $50.00 | +24.32% | Maintains | 2 months ago |
Phathom Pharmaceuticals IncPHAT | 4 | Strong Buy | $25.00 | +110.61% | Maintains | 3 months ago |
Praxis Precision Medicines IncPRAX | 5 | Strong Buy | $800.00 | +133.52% | Maintains | 3 months ago |
Roivant Sciences LtdROIV | 4 | Strong Buy | $30.00 | +2.42% | Maintains | 3 months ago |
Immunovant IncIMVT | 5 | Strong Buy | $44.00 | +60.06% | Maintains | 3 months ago |
Avalo Therapeutics IncAVTX | 1 | Strong Buy | $50.00 | +181.85% | Initiates Coverage On | 3 months ago |
Sab Biotherapeutics IncSABS | 1 | Strong Buy | $15.00 | +305.41% | Initiates Coverage On | 5 months ago |
Anaptysbio IncANAB | 10 | Strong Buy | $100.00 | +58.35% | Maintains | 6 months ago |
Rapt Therapeutics IncRAPT | 3 | Strong Buy | $70.00 | +20.65% | Initiates Coverage On | 7 months ago |
Abivax SaABVX | 3 | Strong Buy | $150.00 | +30.97% | Maintains | 7 months ago |
Moonlake ImmunotherapeuticsMLTX | 4 | Strong Buy | $20.00 | +13.96% | Maintains | 8 months ago |
Tourmaline Bio IncTRML | 3 | Hold | $48.00 | +0.04% | Downgrades | 8 months ago |
Forte Biosciences IncFBRX | 1 | Strong Buy | $75.00 | +224.53% | Initiates Coverage On | 9 months ago |
Larimar Therapeutics IncLRMR | 6 | Strong Buy | $26.00 | +626.26% | Reiterates | a year ago |
Gh Research PLCGHRS | 1 | Strong Buy | $29.00 | N/A | Maintains | a year ago |
Zura Bio LtdZURA | 2 | Strong Buy | $15.00 | N/A | Reiterates | a year ago |
Surrozen IncSRZN | 3 | Strong Buy | $45.00 | N/A | Upgrades | a year ago |
Spyre Therapeutics IncSYRE | 1 | Strong Buy | $65.00 | N/A | Maintains | 2 years ago |
Vigil Neuroscience IncVIGL | 2 | Strong Buy | $16.00 | N/A | Maintains | 2 years ago |
Q32 Bio IncQTTB | 1 | Strong Buy | $100.00 | N/A | Initiates Coverage On | 2 years ago |
Celldex Therapeutics IncCLDX | 4 | Strong Buy | $90.00 | N/A | Maintains | 2 years ago |
Longboard Pharmaceuticals IncLBPH | 3 | Strong Buy | $32.00 | N/A | Maintains | 2 years ago |
Xenon Pharmaceuticals IncXENE | 2 | Strong Buy | $49.00 | N/A | Reiterates | 3 years ago |
Eyepoint IncEYPT | 2 | Strong Buy | $55.00 | N/A | Maintains | 3 years ago |
Bioxcel Therapeutics IncBTAI | 2 | Strong Buy | $736.00 | N/A | Maintains | 3 years ago |
Prometheus Biosciences IncRXDX | 3 | Hold | $200.00 | N/A | Downgrades | 3 years ago |
Acadia Pharmaceuticals IncACAD | 5 | Strong Buy | $22.00 | N/A | Upgrades | 3 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 1 | Hold | $116.50 | N/A | Downgrades | 3 years ago |
Sage Therapeutics IncSAGE | 3 | Strong Buy | $48.00 | N/A | Maintains | 4 years ago |
Reata Pharmaceuticals IncRETA | 1 | Strong Buy | $75.00 | N/A | Initiates Coverage On | 4 years ago |
Relmada Therapeutics IncRLMD | 3 | Hold | N/A | N/A | Downgrades | 4 years ago |
Karuna Therapeutics IncKRTX | 1 | Strong Buy | $330.00 | N/A | Maintains | 4 years ago |
Bausch & Lomb CorpBLCO | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 4 years ago |
Climb Bio IncCLYM | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Seelos Therapeutics IncSEELQ | 1 | Strong Buy | $30,720.00 | N/A | Initiates Coverage On | 5 years ago |
Global Blood Therapeutics IncGBT | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 7 years ago |
Seagen IncSGEN | 1 | Strong Buy | $80.00 | N/A | Upgrades | 8 years ago |
Verona Pharma PLCVRNA | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.